Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105
June 05, 2023 08:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Inventiva annonce que son partenaire Sino Biopharm a reçu l'approbation de sa demande d’IND par la NMPA pour démarrer le développement clinique de lanifibranor en Chine
May 25, 2023 16:00 ET
|
INVENTIVA
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., filiale de Sino Biopharm, a reçu l'approbation de sa demande d’IND par la NMPA permettant l’initiation du développement clinique en Chine...
Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China
May 25, 2023 16:00 ET
|
INVENTIVA
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASHSino...
Grom’s Curiosity Ink Media Announces Licensing and Partnership Opportunities for Cats vs Pickles, Denver, the Last Dinosaur and Santa.com at International Licensing Expo 2023
May 18, 2023 09:00 ET
|
Grom Social Enterprises
BOCA RATON, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom'' or the “Company”), a media, technology, and entertainment company dedicated to...
ProgWebT Wins In PTAB Trial Against Tencent, Key Patent for PWA and Mini Apps Technology having Multi-Billion Revenues
May 11, 2023 11:27 ET
|
ProgWebT LLC
DOVER, Del., May 11, 2023 (GLOBE NEWSWIRE) -- ProgWebT LLC, a pioneering technology company based out of Delaware, recently secured a significant victory in a Patent Trial and Appeal Board (PTAB)...
TSplus License Portal Now Offers Remote Support Credits
April 24, 2023 10:47 ET
|
TSplus
IRVINE, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- TSplus, the innovative provider of remote desktop and application delivery solutions, is pleased to announce the latest improvements to its License...
Kane Biotech Announces Additional coactiv+™ Animal Health Licensing Agreement
April 18, 2023 07:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that it has signed a licensing agreement with...
electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan
April 11, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Teijin...
VitalHub Announces Licensing of SHREWD Solution in Canada, With The Winnipeg Regional Health Authority
March 13, 2023 07:30 ET
|
Vitalhub Corp.
TORONTO, March 13, 2023 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it has partnered with the Winnipeg Regional Health...
uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1
January 31, 2023 07:05 ET
|
uniQure Inc.
~ License of APB-102 further strengthens uniQure’s pipeline of innovative gene therapies to treat neurological disorders and miRNA-based gene silencing programs ~ ~ APB-102 and uniQure’s c9orf72-ALS...